Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with PwC's Global Pharmaceutical and Life Sciences Cyber Leader, Nalneesh Gaur and PwC's Cybersecurity Principal, Robbie Higgins, on cybersecurity issues and privacy laws that pharmaceuticals and life sciences companies are dealing with in China. This episode includes insights and implications of: 

• China Cybersecurity Law
• Multi-layer Protection Scheme 2.0
• Data Security Law
• Personal Information Protection Law

Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky, in discussion with PwC Strategy& Director, Rohit Nayak, PwC Strategy& Senior Manager, Sri Murthy Guru and PwC Strategy& Senior Associate, Cailin Hong, on what physicians are seeking from payers, health systems and management services organizations (MSOs), to help improve the practice of medicine. This episode includes:

• Emerging business models and solutions that can enhance the physician experience
• The role of payers and providers in driving physician enablement within the health ecosystem
• Actions health organizations should consider to help support and encourage their physicians

Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC Health Industries Vice Chair, Jenny Colapietro, in discussion with US Pharmaceutical & Life Sciences Deals Leader, Glenn Hunzinger and US Health Services Deals Leader, Nick Donkar, on current deal trends impacting the health sector. This episode includes:

• Significant mergers and acquisitions of 2021
• Future deal drivers for 2022 and the potential impact on current trends
• Deal growth activity in healthcare and pharma & life sciences subsectors

Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky, in discussion with PwC Director, Sierra Hawthorne, PwC Strategy& Managing Director, Josette Beran, and The PwC Katzenbach Center Managing Director, Reid Carpenter, on the current state of the health industry and three trends to watch for in 2022, including:

• Investing in our workforce
• Building trust
• Creating financial sustainability

Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC Health Industries Vice Chair, Jenny Colapietro, in discussion with the Founder & CEO of Concert Health, Spencer Hutchins, on the evidence-based health care model that will help tighten the gaps in our behavioral and mental health services. This episode includes:

• How Concert Health’s collaborative care model addresses issues around healthcare access and integration
• The importance of integration and partnerships with providers and payors in addressing behavioral health
• Leveraging data and analytics to drive growth and innovation in behavioral health services
• Key considerations to reduce racial disparities and prevent burnout in behavioral health care

Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC Principal, Omar Chane, and PwC Managing Director, Amy Hunckler, on the evolution of the vaccines market and mRNA technology, including:

• The impact of new entrants on the vaccine industry
• Manufacturers' role in improving the customer experience
• How mRNA and its various applications will continue to shape the pharmaceutical and life sciences industry

Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC's Pharmaceutical and Life Sciences Research and Development Principals, Anup Kharode and Brian Slizgi, on the evolution of the clinical trial delivery model, including:

• Impact of COVID-19 on clinical trials and research
• Emerging trends and disruptors
• Implications for clinical research organizations (CROs) and the broader pharmaceutical industry
• The future of decentralized clinical trials

Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC Director, James Lin, on price transparency regulations, including:

• Key implications and considerations for payers, providers and pharma and life sciences
• Impacts to consumer behavior and market pricing
• How to improve the relationship between price and quality transparency.

Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC’s Consulting Solutions Director, Aparna Kumar, on how the next generation is transforming philanthropy to drive organizational success and social change, including:

• The current philanthropic funding landscape
• Benefits of strategic partnerships
• The role of technology in shaping the future of philanthropy
• Bridging the relationship between philanthropy and ESG

Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC Principal, Kevin McLellan, on the latest medical device trends and innovations, including:

• Shifting consumer and patient engagement
• Implications of connected devices and data on care experience
• Differentiated growth opportunities for medical technology to unlock value and reimagine tradition care model

Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC Principal, Paul Leinwand, PwC Director, Inshita Wij and PwC Senior Manager, Lauren Christian, on recent consumer healthcare survey findings, including:

• What consumers are seeking from their healthcare experience and how health systems can respond
• Must-haves for improving consumer experience and loyalty
• The demand for virtual care persists
• Future considerations for health organizations to increase consumer engagement

Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, on the long-respected history of bloodletting, including:

• Barber surgeons and early medicine
• The practice and evolution of bloodletting
• The influence of ancient principles on modern medicine

Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with PwC’s Partner, Derek Gaasch, on how health insurance companies can optimize their member engagement, to help them achieve better health, including:

• The consumerization of health
• The importance of advocacy for members and health insurers
• Proactive efforts to increase members’ health and wellness engagement
• Technology’s impact on member advocacy

Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with PwC’s Consulting Solutions Director, Aparna Kumar, on how the U.S. can overcome the shortage of healthcare workers, including:

• Physician workforce projections released in The Association of American Medical Colleges’ (AAMC) annual report
• The pandemic’s impact on the physician shortages
• Decreasing regulatory barriers for internationally educated physicians could ease the burden of physician shortages
• Short-term strategies to address physician workforce shortages

Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with Carrum Health’s CEO, Sachin Jain and SVP of Provider Partnerships, Christoph Dankert, on healthcare marketplace and delivery transformation, including:

• The role of value based care and price transparency in addressing current state issues such as physician incentive misalignment
• The impact of shifting power, behavior and quality dynamics between providers, payers, employers and consumers
• The role of bundles, and the influence of data and technology, in driving meaningful prices, quality of care and the overall healthcare experience

Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with US Pharmaceutical & Life Sciences Deals Leader, Glenn Hunzinger and US Health Services Deals Leader, Nick Donkar, on the current deals activity impacting the health and pharma and life sciences sectors, including: 

• Tailwinds that are driving sector deals activity and growth
• Headwinds that pose challenges for deals activity
• Factors that can influence merger and acquisition success
• Deals landscape outlook 

Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with Pharmaceutical Quality Partner, Jan Paul Zonnenberg, on the importance of drug quality in the health ecosystem, including:

• The history and current state of pharmaceutical quality in the U.S.
• Patient trust and quality in the drug development ecosystem
• What forces are accelerating quality improvements?
• The role of culture in improving drug quality

Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, discuss how consumers are accessing their healthcare post pandemic, including:

• Challenges and implications of differing perspectives among provider executives and consumers on virtual health
• Considerations for delivering a personalized virtual health experience
• New entrants' role in shaping the health system
• Importance and influence of consumer preferences in optimizing the care delivery experience

What does the coming year and new decade hold for healthcare? What are the key healthcare business issues and trends for 2020 that will impact you and your organization, and how can you best position for them? Attend this web summit event and get 2020 vision for your healthcare organization. The Eighteenth Annual Future Care Web Summit addresses key future trends and also focuses on several important cutting-edge healthcare business topics, including:

• Forces of Change: The Future of Healthcare into 2040
• The Legal, Regulatory and Policy Landscape for 2020
• Social Determinants of Health Program & Policy Developments for 2020
• On-Demand Sessions: Transformation Through Digitally Enabled Care, MSSP Pathways to Success

A discussion on how Payors can avoid certain problems associated with narrow networks and give themselves a clear competitive advantage by designing high-performing health networks using three criteria.